Physician profile
Anthony Quinn
NPI 1558621151
$1,184.32
in general payments reported to CMS, 2019-2025
13 companies · $106 in 2025
The $106 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $571 · 2020: $249 · 2021: $23.89 · 2022: $128 · 2023: $22.47 · 2024: $84.08 · 2025: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $212.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $250.88 | 2020-2025 | Nuplazid |
| Sunovion Pharmaceuticals INC. | $216.30 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $186.74 | 2019 | |
| Neurocrine Biosciences, INC. | $127.59 | 2022 | |
| Alkermes, INC. | $96.80 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $80.37 | 2025 | Austedo Xr |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $80.35 | 2019 | |
| Allergan, INC. | $34.48 | 2019 | |
| Lundbeck LLC | $34.06 | 2019 | |
| Avanir Pharmaceuticals, INC. | $23.89 | 2021 | |
| Shire North American Group INC | $20.55 | 2019 | |
| Vanda Pharmaceuticals INC. | $16.93 | 2019 | |
| Sun Pharmaceutical Industries INC. | $15.38 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Quinn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.